Dynamics of sphingolipids and the serine palmitoyltransferase complex in rat oligodendrocytes during myelination

Abstract

Myelin is a unique lipid-rich membrane structure that accelerates neurotransmission and supports neuronal function. Sphingolipids are critical myelin components. Yet sphingolipid content and synthesis have not been well characterized in oligodendrocytes, the myelin-producing cells of the CNS. Here, using quantitative real-time PCR, LC-MS/MS-based lipid analysis, and biochemical assays, we examined sphingolipid synthesis during the peak period of myelination in the postnatal rat brain. Importantly, we characterized sphingolipid production in isolated oligodendrocytes. We analyzed sphingolipid distribution and levels of critical enzymes and regulators in the sphingolipid biosynthetic pathway, with focus on the serine palmitoyltransferase (SPT) complex, the rate-limiting step in this pathway. During myelination, levels of the major SPT subunits increased and oligodendrocyte maturation was accompanied by extensive alterations in the composition of the SPT complex. These included changes in the relative levels of two alternative catalytic subunits, SPTLC2 and -3, in the relative levels of isoforms of the small subunits, ssSPTa and -b, and in the isoform distribution of the SPT regulators, the ORMDLs. Myelination progression was accompanied by distinct changes in both the nature of the sphingoid backbone and the N-acyl chains incorporated into sphingolipids. We conclude that the distribution of these changes among sphingolipid family members is indicative of a selective channeling of the ceramide backbone toward specific downstream metabolic pathways during myelination. Our findings provide insights into myelin production in oligodendrocytes and suggest how dysregulation of the biosynthesis of this highly specialized membrane could contribute to demyelinating diseases. Myelin is a unique lipid-rich membrane structure that accelerates neurotransmission and supports neuronal function. Sphingolipids are critical myelin components. Yet sphingolipid content and synthesis have not been well characterized in oligodendrocytes, the myelin-producing cells of the CNS. Here, using quantitative real-time PCR, LC-MS/MS-based lipid analysis, and biochemical assays, we examined sphingolipid synthesis during the peak period of myelination in the postnatal rat brain. Importantly, we characterized sphingolipid production in isolated oligodendrocytes. We analyzed sphingolipid distribution and levels of critical enzymes and regulators in the sphingolipid biosynthetic pathway, with focus on the serine palmitoyltransferase (SPT) complex, the rate-limiting step in this pathway. During myelination, levels of the major SPT subunits increased and oligodendrocyte maturation was accompanied by extensive alterations in the composition of the SPT complex. These included changes in the relative levels of two alternative catalytic subunits, SPTLC2 and -3, in the relative levels of isoforms of the small subunits, ssSPTa and -b, and in the isoform distribution of the SPT regulators, the ORMDLs. Myelination progression was accompanied by distinct changes in both the nature of the sphingoid backbone and the N-acyl chains incorporated into sphingolipids. We conclude that the distribution of these changes among sphingolipid family members is indicative of a selective channeling of the ceramide backbone toward specific downstream metabolic pathways during myelination. Our findings provide insights into myelin production in oligodendrocytes and suggest how dysregulation of the biosynthesis of this highly specialized membrane could contribute to demyelinating diseases. Myelin is a highly specialized membrane that wraps around axons in the central and peripheral nervous systems, accelerating neuronal transmission and sustaining neuronal function and viability. Loss of myelination is the pathological basis for several devastating neurological disorders, collectively known as demyelinating diseases, the most common of which is multiple sclerosis (1Stadelmann C. Timmler S. Barrantes-Freer A. Simons M. Myelin in the central nervous system: structure, function, and pathology.Physiol. Rev. 2019; 99: 1381-1431Crossref PubMed Scopus (79) Google Scholar). The myelin membrane is an extension of the plasma membrane of specialized cells; oligodendrocytes in the CNS and Schwann cells in the peripheral nervous system. The composition of myelin is highly distinct from other biological membranes with regard to both protein and lipid composition. Lipids compose approximately 80% (by weight) of myelin, as compared with 50% in most other biological membranes Myelination in rat changes in myelin composition during PubMed Scopus Google Scholar). The lipid of myelin and levels of sphingolipids. that 80% of the lipid in myelin was sphingolipid A. myelination PubMed Scopus Google Scholar). The of myelin sphingolipid is the for the and and which is a Myelin of Myelin the unique of this membrane in membrane in to myelin PubMed Scopus Google and membrane the myelin structure and myelin and A. and of myelin lipid the neurological in and PubMed Scopus Google M. The and of in the nervous PubMed Scopus Google and myelin PubMed Scopus Google S. S. is for the of CNS myelin and PubMed Scopus Google C. S. insights into the critical of in myelin PubMed Scopus Google Scholar). The of myelin is by the that in the production of have in myelination A. of the lipid of the myelin membrane in central and peripheral nervous by PubMed Scopus Google and of isoforms in the central nervous of PubMed Scopus Google and of in myelin structure that as S. S. is for the of CNS myelin and PubMed Scopus Google and 99: PubMed Scopus Google Scholar). The production of with the and in the pathway, serine palmitoyltransferase a protein in the in biosynthesis in and PubMed Google this serine with to an of sphingolipids. is that of this a step for sphingolipid biosynthesis for myelin SPT is a that a of two subunits, most and SPTLC2 the of the is not by with for and the SPTLC2 by a SPT is by The small SPT subunits, ssSPTa and -b, of the SPT complex. to the of SPT the composition of SPT which S. of small subunits of serine palmitoyltransferase that distinct PubMed Scopus Google Scholar). The by the and which are the most on the the of both and and common sphingoid The of these alterations are not changes in SPT as we suggest that these changes the of the sphingolipid of SPT is SPT is sphingolipid levels the in ceramide PubMed Scopus Google of sphingolipid biosynthesis in by PubMed Google Scholar). of the that with SPT in M. and PubMed Scopus Google cells isoforms have to well The to ceramide major function of this to sphingolipid biosynthesis to the ceramide SPT this is to which by of the ceramide to which is by ceramide to the central for in in and PubMed Scopus Google ceramide a distinct for of from to in and a of ceramide are is the backbone for by the of from by the for myelin ceramide is the backbone of in in from and PubMed Scopus Google The synthesis of is by the of to ceramide by ceramide is by to by of several to in C. in sphingolipid and in and PubMed Scopus Google and by of the two to the both of which are for the that the in M. S. S. and in PubMed Scopus Google Here, we analyzed the rat during the postnatal peak of myelination with to levels of and sphingolipid metabolic Importantly, for the we analyzed these in isolated oligodendrocytes to into myelin production that is not Our was to the basis for the that both the and lipid of myelin sphingolipid production and how in demyelinating diseases. The in this protein and from and from was from was from protein was from was from was from was from for and from and was from real-time in this from as and for rat and for is included in the and from was from from The was from for from Lipids to in as a of for sphingoid and sphingoid and for N-acyl and was from and was from was from and from and from was from from and and from and and and in with the of for the and of and by the and of isolated from rat and using a and from C. of oligodendrocytes and using and Google isolated postnatal are oligodendrocyte from are a that into The of cells isolated from are oligodendrocytes. by the of The from the and was in in was the and in and was to a and for in a was to and was by with for and with of A. The was a to a with and to a of and for in a using a isolated from the with to and in The cells in a and for to for of and the oligodendrocytes and into for and protein a from C. A. and from PubMed Scopus Google Scholar). postnatal in this from rat and in the was using and of into in a and using the by the to on and for to and to in a and for to in and approximately a protein was using the protein and for SPT assays, of the from rat was into and using and of on and to a and was to a which of and for approximately by for The was to a and of to to was by for using a with and using on content was using a and and the of the isolated to of was using a for PubMed Scopus Google Scholar). was using of isolated from the of rat We the from the quantitative for of and from was using of with and a real-time system. analyzed using the with to and relative to on using as in PubMed Scopus Google Scholar). to membranes and with in for to in of on and with membranes for using on a membranes with in to for using and a of SPT we a to in membranes from postnatal rat from A. of using to SPT in PubMed Scopus Google of membrane protein for in of using with and in a lipid could of as an and by of and for which the was The was with of the was and in of to to the of into was using a to a and to an in a and to and a multiple in using to in was from by the was to The by using a and a a of with a to to of the the was for with a of with and with and the was for by a to which was for by a to The was with for the SPT is as of of into with a of and of with the of in a of of The using an for was of in in a for to The was to with of the was using a and the was by a and to a The was to using a The was in of the for analysis, for approximately and for in a of the to the for These by using a and a a of with a to to of the the was for with a of with and with and the was for by a to which was for by a to The was with for the and by the biological that both analyzed by a in with The was with with for the was and the was for and using this and the of by this with the of and was of the with the other during by using a and a a of with a to to of the the was for with a of and and the was for by a to which was for by a to The was with for the analyzed in using an of the for been to in to N-acyl the basis for the of sphingolipid during myelination in the we the myelination in the from postnatal to postnatal from several the of myelination in this we the protein and levels of major myelin myelin oligodendrocyte protein and myelin The for these in the rat and to around of is by the and of the myelin oligodendrocyte and major isoforms of protein These are with that myelination in the rat is around postnatal and to to levels by of the of myelination is of myelin in the PubMed Scopus Google of myelin protein in PubMed Scopus Google Scholar). We a of in during this period of myelination. this is to that in to the of myelination, the two postnatal and in and and these contribute to the sphingolipid and are to specific and myelin components. Our included that the of to myelin production and function is and M. of and myelin in PubMed Scopus Google M. M. of is with and myelin PubMed Scopus Google Scholar). The to as is a distinct of we levels of in these and that the levels of of the of and is by increased of the that by of We the levels of the ceramide known as and and with a is the of of the ceramide from to of and levels of this C. of the ceramide during myelination of the nervous system. with the myelin and PubMed Scopus Google in rat myelin during PubMed Scopus Google Scholar). is with an increased production of as a of myelin as well as to the production of is an in the production of the sphingolipid of myelin, is levels an for PubMed Scopus Google Scholar). is not that the levels of ceramide the of myelination to a postnatal that is approximately that postnatal is to other by and S. of Sphingolipids in the and Myelination in during of Google using of ceramide are approximately an of of the of a of the myelin are in during the of myelination is that is a of the levels of are a and are in the sphingolipid pathway. is a of ceramide by is in the biosynthetic to ceramide of during postnatal to levels postnatal that are approximately postnatal both the of as well as the of of during the period of myelination, are in the this a of sphingolipid is to that these are levels are the of both production and of metabolic is with the that the levels of the are of of the downstream sphingolipid The of the and are and and metabolic in M. S. S. and in PubMed Scopus Google levels of both of these in to the specific myelin not postnatal to The of this which the peak of myelination, that these are in and in the rat in a in the PubMed Scopus Google We not an in the in isolated oligodendrocytes during this period is that oligodendrocyte and is on in on and PubMed Scopus Google C. S. an with function on and PubMed Scopus Google M. S. C. of as a of in oligodendrocyte PubMed Scopus Google M. of oligodendrocyte PubMed Scopus Google Scholar). to that is an is of the oligodendrocytes and The are from of during the postnatal that the period of myelination. of the and enzymes as and in the myelin-producing oligodendrocytes, other from and which are and during this period in in and of maturation and to PubMed Scopus Google this we isolated oligodendrocytes and to the period of peak myelination. for these are from oligodendrocytes isolated from the of rat oligodendrocytes, levels of are in cells isolated from and a in cells isolated Here, we the into the two major and These with the major is and is from myelin M. of synthesis not in CNS myelin the of PubMed Scopus Google Scholar). in a as the isolated oligodendrocytes, as in the levels of during this in to the levels of a in oligodendrocytes as myelination is to that during the of the oligodendrocytes is that are and is that these levels of in the SPT is the and rate-limiting step in sphingolipid biosynthesis in biosynthesis in and PubMed Google The of SPT is a most of and subunits are for the is to as SPTLC2 in the complex. are two subunits, ssSPTa and -b, which SPT and S. of small subunits of serine palmitoyltransferase that distinct PubMed Scopus Google Scholar). is the for other with ssSPTa in a that S. of small subunits of serine palmitoyltransferase that distinct PubMed Scopus Google Scholar). SPT is in to changes in sphingolipid is by small membrane the of which are isoforms in cells in M. and PubMed Scopus Google the of sphingolipid biosynthesis to myelin, is that the SPT is during the period of myelination. The of that is by in the SPT in myelin-producing which myelination S. M. C. C. the sphingolipid synthesis to myelination and function in 2019; PubMed Scopus Google Scholar). SPT was in membranes using a and specific A. of using to SPT in PubMed Scopus Google Scholar). increased from to and is the in sphingolipid synthesis that is during this of the protein levels of the major SPT subunits that levels of SPTLC2 the levels of SPT levels of is with the levels of these as by real-time SPTLC2 in the SPT complex. both protein and levels of to a peak and a in the composition of the SPT during this critical of myelination. is the in levels of the small SPT subunits ssSPTa and ssSPTa levels during the of myelination levels of These subunits both the and of and how this SPT during myelination is in the The isoforms by The of which the the levels of these the that is a in the of as myelination in a levels in that and changes in in the brain. a from in isolated levels of the SPT and small subunits are in the rat brain. was isolated from the of postnatal of as in was and levels of the subunits, SPTLC2 and as well as the small subunits, ssSPTa and have been to levels and relative to are as levels of the isoforms are in the rat brain. was isolated from the of postnatal of as in was and levels of and as well as the have been to levels and relative to are as in isolated oligodendrocytes, of the the myelination and as the protein and is in cells isolated from as myelination from to of of the the that is in oligodendrocyte from as cells from into cells the of the period of myelination around postnatal levels in cells postnatal the of isolated oligodendrocytes are oligodendrocytes of myelination. levels of which from are in cells from by by the cells are These the that the of the changes in and content in the during myelination is by oligodendrocyte M. ceramide and that not PubMed Scopus Google Scholar). changes in the SPT in the progression of the oligodendrocyte and myelination we the levels of SPT subunits in isolated oligodendrocytes of and increased both the protein and levels in oligodendrocytes as the cells from oligodendrocyte into oligodendrocytes to a to the in levels of and SPTLC2 the period These that other oligodendrocytes the of these in the brain. The in SPT in oligodendrocytes is with the increased to the for myelination. protein levels of during this period is a in levels The these two to The of the in in the the levels of to and The of the small subunits changes in the composition of the SPT oligodendrocytes, the levels of ssSPTa are to the of ssSPTa the in is and is this is to is in the The protein levels of the not during this period of of the isoforms that the relative of the isoforms changes of and during myelination, levels of These that the levels of the SPT during the peak of myelination, that the composition of the changes both with to the major and subunits, changes both in the levels and of The in with ssSPTa as a and the sphingoid other a of S. of small subunits of serine palmitoyltransferase that distinct PubMed Scopus Google Scholar). to and the composition of the SPT to the of sphingoid the of the changes in SPT composition on the of we examined the levels of and sphingoid in isolated oligodendrocytes during the period of peak myelination levels of during the examined we have the levels of these as a of the major sphingolipids. The in and a of is a in these levels a of of ceramide and during this of the of these The levels of to the by to approximately of the The to and incorporated into from to and on The and biological of is by the N-acyl of A. and of N-acyl a into sphingolipid PubMed Scopus Google in A. of ceramide and biological PubMed Scopus Google and is known to myelination A. S. by of ceramide synthesis to PubMed Scopus Google Scholar). We that the content of in and isolated oligodendrocytes changes during the period of myelination we the and These 80% of the The most is in oligodendrocytes, in which of the is a in the of the and an of the as myelination the of in the of and major in which the major in ceramide are the content of and approximately of the and not have a distribution to that of with a of 80% of the ceramide of and myelination is a toward ceramide in oligodendrocytes, not in brain. in oligodendrocytes, the content to and by to oligodendrocytes, not the levels of the are of are approximately of the and to by The of the are of and the are to in are distinct The content of in from to oligodendrocytes, the into and approximately 80% of The of content of oligodendrocyte the of is from to from in levels of and levels of with a in the content as myelination The of both and the as myelination The incorporated into are to in the The in are in and isolated oligodendrocytes both the composition of in oligodendrocytes, the a to of the content The in ceramide and the is an of selective downstream ceramide in in the The production of myelin by oligodendrocytes in the CNS the synthesis and of a specialized of and (1Stadelmann C. Timmler S. Barrantes-Freer A. Simons M. Myelin in the central nervous system: structure, function, and pathology.Physiol. Rev. 2019; 99: 1381-1431Crossref PubMed Scopus (79) Google Scholar). Myelin is highly with a distinct of compared with other biological membranes and that are not in The that and the production of lipid and protein to the composition of this critical membrane is is for a of the production of this highly specialized membrane and for how dysregulation could contribute to devastating demyelinating diseases. we have on the sphingolipid of the and in S. Simons M. and of in PubMed Scopus Google We a of the levels of these in brain. The of in during the postnatal peak of myelination both myelin production and the of neuronal and focus on myelin we for the of in oligodendrocytes during this we the of metabolic enzymes in this pathway, with a focus on the and step in sphingolipid the levels of and as well as the enzymes that the and in both the and oligodendrocyte as the period of myelination the of is with as a of is the of ceramide levels as myelination as we and as ceramide and PubMed Scopus Google Scholar). is as a for the and ceramide levels The of of the lipid PubMed Scopus Google Scholar). are changes in the composition of the that the of this We and that as myelination is a in the levels of and ceramide and PubMed Scopus Google M. with chains in oligodendrocytes by PubMed Scopus Google and a in the and this is in the as and in the in as well in in isolated oligodendrocytes. toward a in the of which and an increased of which ceramide and PubMed Scopus Google A. M. of in of PubMed Scopus Google Scholar). The of the levels of is by the myelination that from of A. S. by of ceramide synthesis to PubMed Scopus Google S. M. ceramide myelin and PubMed Scopus Google Scholar). ceramide is to is that this is not for ceramide A. A. and distinct in in PubMed Scopus Google S. A. in sphingolipid composition from to to in PubMed Scopus Google S. M. A. of ceramide and of and membrane PubMed Scopus Google in The and the of PubMed Scopus Google of ceramide to how an increased ceramide by oligodendrocytes. of the distribution of in oligodendrocytes that is selective of ceramide in of sphingolipids. in the peak period of myelination levels of this are in the levels of are in the as myelination are a in and is the major this is a in the of from of synthesis in the to the for synthesis and to the for synthesis in and of sphingolipid enzymes and lipid PubMed Scopus Google synthesis in the and not a The ceramide for ceramide to the for is selective for S. M. basis for specific lipid by for of PubMed Scopus Google S. M. S. of of PubMed Scopus Google Scholar). in for the of these in The of ceramide to the of the for synthesis is and of sphingolipid enzymes and lipid PubMed Scopus Google M. and lipid from the to the PubMed Scopus Google Scholar). is in this to The ceramide and that the is both ceramide and are of is that is a of the sphingolipid in oligodendrocytes. Yet myelin levels of M. of synthesis not in CNS myelin the of PubMed Scopus Google Scholar). is a selective of sphingolipid into the myelin membrane that and for and is that of synthesis in oligodendrocytes not have on myelination M. of synthesis not in CNS myelin the of PubMed Scopus Google the of in oligodendrocyte function We examined the of the rate-limiting in sphingolipid that SPT during myelination. Our and the of in which the of are during the period that we We that SPT in the of myelination to as myelin is The was with the of SPTLC2 and the protein and levels during this SPT to myelination is to the synthesis that the of and as are major of the neuronal membranes M. The of in the PubMed Scopus Google Scholar). The the of SPT in during the period of levels of myelin production was by of SPT protein and in oligodendrocytes, a in the brain. of the major SPT subunits the in oligodendrocytes that and levels are are was not oligodendrocyte to to that the and levels SPT of SPT with regard to and and is on the composition of the in and of serine PubMed Scopus Google alterations in the SPT composition the is SPTLC2 and the small subunits, ssSPTa -b, and the are The for SPT is the and this is the of the complex, sphingoid the major that we and have of for SPTLC2 the of the and sphingoid A. A. The of serine palmitoyltransferase sphingoid PubMed Scopus Google Scholar). we that the sphingoid are in that we levels The levels of the of the and are The of the distinct and peak in the of the myelination in both and oligodendrocyte is not the of an as function of the that is critical for the of oligodendrocyte maturation and the of myelin The small subunits, in to the of the the of SPT S. of small subunits of serine palmitoyltransferase that distinct PubMed Scopus Google Scholar). the of the of and in the of to the of We a in levels in both and oligodendrocyte during the peak period of myelination. the levels of in oligodendrocytes during this period The levels of these are to of the the levels of to the of these a a in levels of and in a S. of to a in serine palmitoyltransferase small in PubMed Scopus Google Scholar). Our that the composition of the SPT changes during oligodendrocyte and myelination that are alterations of the that are that have for myelin function. The are regulators of of this as in M. and PubMed Scopus Google The to levels of ceramide The palmitoyltransferase (SPT) is by of SPT in isolated 2019; PubMed Scopus Google Scholar). are the isoforms are the in ceramide PubMed Scopus Google Scholar). is to ceramide levels levels by that SPT of ceramide production not enzymes downstream of in as the in which levels of sphingolipid are been that a of and in myelin S. M. C. C. the sphingolipid synthesis to myelination and function in 2019; PubMed Scopus Google Scholar). These of axons in the myelin, to of the myelin The that sphingolipid production is both to oligodendrocytes and in myelin We that in the oligodendrocytes the of protein is that the of the isoforms isoforms by of levels that the of the isoforms changes as oligodendrocytes of with oligodendrocyte in the cells from These cells of to the of oligodendrocyte maturation into levels of during this to how the in isoform composition SPT and how these to the of and S. M. C. C. the sphingolipid synthesis to myelination and function in 2019; PubMed Scopus Google Scholar). is that isoform a ceramide to a of ceramide is that the have on other of sphingolipid These that the of sphingolipid content in the myelin membrane been known for is the biosynthesis and of these into the myelin in how the levels of are in the both in to other and to the protein of to the sphingolipid biosynthesis with the nature of the of these two lipid in myelination in in myelin and PubMed Scopus Google The that both the protein and lipid of myelin from of synthesis into the myelin membrane is of the of myelin biosynthesis to the of of demyelinating by The is by the of to the as well as a from the of with myelin protein myelin oligodendrocyte protein serine palmitoyltransferase

Topics & Concepts